Nasal Compression Device Study for Epistaxis

Launched by NASACLIP · Mar 15, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new device designed to help stop nosebleeds, specifically those that come from the front of the nose, known as anterior epistaxis. The purpose of the study is to see how well this nasal compression device works compared to the traditional method of manually pressing on the nose to stop the bleeding. Participants who come to the hospital with a nosebleed may be invited to join the study, where they will either use the new device or receive standard care. Afterward, they will answer some questions about how satisfied they were with the treatment and how comfortable they felt using the device.

To participate in this study, individuals must be at least 18 years old and be experiencing a nosebleed that can be controlled with pressure. They should also be in generally good health and willing to follow the study's procedures. However, people with certain health conditions, allergies to the device's materials, or those who are pregnant or unable to give consent will not be eligible. Participants can expect to receive focused care for their nosebleed and to provide feedback on their experience with the treatment. The study is currently looking for volunteers and aims to gather important information to improve care for people with nosebleeds.

Gender

ALL

Eligibility criteria

• • INCLUSION
• In order to be eligible to participate in this study, an individual must meet all of the following criteria:
• • 1. Presenting with anterior epistaxis determined as someone with venous bleeding that can be controlled with external compression.
• • 2. Stated willingness to comply with all study procedures and availability for the duration of the study.
• • 3. Male or female, aged at least 18.
• • 4. In good general health as determined by the PI or Sub-I(s).
• • EXCLUSION
• An individual who meets any of the following criteria will be excluded from participation in this study:
• • 1. Known allergic or hypersensitivity reactions to components of NasaClip or oxymetazoline.
• • 2. Less than 18 years of age.
• • 3. Known pregnancy.
• • 4. Unable to provide informed consent.
• • 5. Subjects who are prisoners or who are in police custody.
• • 6. Identified by the medical team as having an acute exacerbation or poor control of any of the following medical conditions: high blood pressure, heart disease, thyroid disease, diabetes, trouble urinating due to an enlarged prostate.
• • 7. Patients taking MAO inhibitors.
• • 8. Medical instability or need for emergent intervention as determined by on-site medical team.